In SHRSP fed a high-salt diet, rosuvastatin treatment significantly delayed the onset of stroke and attenuated the transcription of inflammatory biomarkers (MCP-1, transforming growth factor-β1, interleukin (IL)-1β, and tumor necrosis factor-α (TNF-α)) [8]. The gene discussed is IL1B; the disease is stroke disorder.